MedTrace Logo

A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease

NCT01113593 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2013-05-27

No results posted yet for this study

Summary

The purpose of this study is to characterize the pharmacodynamic profile of Formoterol Fumarate and Foradil Aerolizer

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Formoterol Fumarate

Inhalation solution

DRUG

Formoterol Fumarate

Inhalation solution

DRUG

Formoterol Fumarate

Inhalation solution

DRUG

Foradil Aerolizer

Dry powder inhaler

DRUG

Foradil Aerolizer

Dry powder inhaler

Sponsors & Collaborators

  • Dey

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01113593 on ClinicalTrials.gov